Skip to main content
. 2015 May 20;290(27):17020–17028. doi: 10.1074/jbc.M115.637124

FIGURE 1.

FIGURE 1.

Representation of the structure of the human prion protein showing the sites where cysteine residues were introduced to permit labeling with IANBD.